About usThe FiberSense company
Since 2006, FiberSense has been working toward a simple idea: biomarker sensing should become more continuous, more personal and easier to integrate into everyday life. Building on the experience of EyeSense, a spin-off from CIBA Vision (Alcon), formerly part of the Novartis Group, FiberSense combines optical sensing expertise with a focus on practical, long-wear and more sustainable monitoring solutions. Our first regulated application is the CE-marked FiberSense CGM System for continuous glucose monitoring in adults with diabetes, designed around long wear duration, reusable components and real-time glucose insights.
Our way
Our journey started in 2007 with concept studies that laid the groundwork for our current developments. Since then, we have consistently advanced our technology with one goal in mind: to reduce the friction of continuous monitoring and make meaningful glucose insights easier to integrate into everyday life. Extended wear time, reusable components and wireless data transfer are not just technical features – they reflect our belief that medical technology should be practical, responsibly designed and built around real life.
Our vision
We believe the future of sensing will be more personal, more continuous and more connected to everyday decisions. FiberSense is starting with continuous glucose monitoring for adults with diabetes, but our long-term vision reaches even further: to advance optical sensing technologies that may one day help people better understand how lifestyle and metabolic factors may relate to everyday wellbeing. Future areas of exploration may include additional metabolic and lifestyle-related signals such as ketones, lactate, cortisol or other indicators relevant to personal metabolic insights.
Our brands
FiberSense is our medical-device brand focused on CE-marked continuous glucose monitoring for adults with diabetes. Nuvia is being developed as a future lifestyle and wellness brand for personal metabolic insights, with potential use cases around nutrition, activity, recovery and everyday routines. This brand architecture allows us to keep medical-device communication clear and compliant, while exploring broader lifestyle-oriented opportunities under a separate brand. Nuvia applications are not part of the current approved intended use of the FiberSense CGM System.
Our team
FiberSense is driven by an experienced team dedicated to shaping the future of medical technology with passion and expertise. Together, we strive to make FiberSense a trusted partner for both our users and investors, firmly believing that the best solutions arise where experience meets innovation.
Michael Tillmann
serves as the Executive Chairman of FiberSense AG and is a strategic investor through his company, Amatar Group. Before this, he spent over eight years at Roche Diagnostics, where he held the positions of CEO for both the Asia Pacific and North America regions and was a member of the Roche Global Executive Board. In these roles, he managed the Diagnostics Division, which included overseeing the Diabetes business. Mr. Tillmann also holds positions on the supervisory boards of multiple private and publicly listed companies and acts as an advisor to both industry and government entities.
Dario Clos
Chief Operating Officer (COO) of FiberSense AG and Managing Director of FiberSense GmbH, oversees the operational activities of the German subsidiary. A qualified industrial engineer with extensive experience in the pharmaceutical and medical technology sectors, Dario brings invaluable expertise to the FiberSense project, focusing on its successful implementation and transition to industrial scale. With +15 years in the diabetes market, he specializes in the industrialization of diabetes treatments, driving innovation and efficiency in delivering transformative therapies to market.
Alessandro Del Fabro
Chief Finance Officer (CFO) of FiberSense AG, is a seasoned financial executive and co-founder of swiss finance leaders gmbh, a Swiss-based firm specializing in financial services for companies in the life sciences and healthcare industries. With extensive experience as Chief Financial Officer, he has been part of management teams in both publicly listed and privately held organizations, driving sustainable growth and strategic transformation. He has successfully led several IPOs of Swiss and European companies and executed complex equity, structured equity, and debt financing rounds with international investors. His expertise extends to establishing supply chains for biotech manufacturing, optimizing integrated financial processes, and streamlining order-to-invoice operations between ERP and CRM systems to enhance scalability and profitability. In addition, Alessandro serves as a Board Member with BioValley in Basel, further contributing to the development of the life sciences ecosystem in the Basel region and across borders into France, Germany and Switzerland. Holding a Swiss CPA qualification from a Big Four audit firm and a degree in Economics from the University of Applied Sciences in Basel, Alessandro combines entrepreneurial spirit with deep technical knowledge, positioning him as a trusted leader in guiding companies through critical growth phases.
Dr. Achim Müller
Chief Technology Officer (CTO) of FiberSense AG and Managing Director of FiberSense GmbH, is the founder and visionary behind FiberSense technology. With over 25 years of experience in medical product research and development, Dr. Müller is recognized as one of the industry’s leading experts. His work is fueled by a commitment to guide innovative products from conception to market readiness, with the goal of expanding treatment options for patients globally.
Dr. Thomas Keller
Chief Commercial Officer (COO) of FiberSense AG, is an international healthcare business leader with experience in both multinational and start-up environments across Europe, Asia-Pacific, Greater China, the Middle East, and Africa. He has successfully transformed commercial operations at Roche Diagnostics, Bayer, Vela Diagnostics, and Eppendorf, consistently achieving above-market growth and building high-performing teams in diagnostics, medical devices, pharmaceuticals, and life sciences. Holding a doctorate in Healthcare Marketing from the University of Mannheim, he combines a flexible leadership style with a proven track record in strategy formulation and execution, business scale-up, and employee engagement across diverse markets and Go-to-Market models.
Dr. Bhuwnesh Agrawal
Chief Medical Officer of FiberSense AG, +40 years of experience in the healthcare industry including clinical and commercial experience. Prior served in companies including Roche (including Diabetes), Eppendorf and Sysmex C suite manager/ CEO. As a medical doctor and industry expert, BA has the know-how to develop the product to conduct the clinical studies for approval and generate data for marketing and sales.
